Scaling up of intermittent preventive treatment of malaria in pregnancy using sulphadoxine-pyrimethamine: Prospects and challenges

Maternal and Child Health Journal

Volumn 15, Issue 4, 2011, Pages 542-552

  Oyibo, Wellington Aghoghovwia ^a   Agomo, Chimere Obiora ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

Coverage; Intermittent preventive treatment of malariain pregnancy (IPTp); Malaria in pregnancy; Scaling up; Sulphadoxine pyrimethamine (SP)

Indexed keywords

ANTIMALARIAL AGENT; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

AFRICA; ARTICLE; COMORBIDITY; DRUG COMBINATION; DRUG RESISTANCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA; PREGNANCY;

AFRICA; ANTIMALARIALS; COMORBIDITY; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HIV INFECTIONS; HUMANS; MALARIA; PREGNANCY; PYRIMETHAMINE; SULFADOXINE;

EID: 80051670674     PISSN: 10927875     EISSN: 15736628     Source Type: Journal    
DOI: 10.1007/s10995-010-0608-5     Document Type: Article

References (88)

1. World Health Organization. (2004). A strategic framework for malaria prevention and control during pregnancy in the African region. WHO Regional Office for Africa, Brazzaville, Republic of Congo. AFR/MAL/04/01. Available at: http://www.who.int/malaria/rbm/Attachment/20041004/malaria-pregnancy-str- framework.pdf.
2. Federal Ministry of Health (FMOH). (2005). National antimalarial treatment policy. Federal Ministry of Health Nigeria, National Malaria and Vector Control Division Abuja, Nigeria, 52 pp.
3. World Health Organization. (1986). WHO expert committee on malaria. Eighteenth report. Geneva. World Health Organization, WHO technical report series.
4. Salihu, H. M., Naik, E. G., Tchuinguem, G., Bosny, J. P., & Dagne, G. (2002). Weekly chloroquine prophylaxis and the effect on maternal haemoglobin status at delivery. Tropical Medicine and International Health, 7, 29-34. (Pubitemid 34131808)
5. Denoeud, L., Fievet, N., Aubouy, A., Ayemonna, P., Kiniffo, R., Massougbodji, A., et al. (2007). Is chloroquine chemoprophylaxis still effective to prevent low birth weight? Results of a study in Benin. Malaria Journal, 6, 27.
6. Bertin, G., Tuikue Ndam, N., Jafari-Guemouri, S., Fievet, N., Renart, E., Sow, S., et al. (2005). High prevalence of Plasmodium falciparum pfcrt K76T mutation in pregnant women taking chloroquine prophylaxis in Senegal. Journal of Antimicrobial Chemotherapy, 55, 788-791. (Pubitemid 40691864)
7. Diallo, M., Dabo, C. A., Saye, R., Yattara, O., Diarra, M. A., Kayentao, K., et al. (2007). Randomized clinical trial of two malaria prophylaxis regimens for pregnant women in Faladie, Mali. Médecine Tropicale, 67, 477-480. (Pubitemid 350157173)
8. Kayentao, K., Mungai, M., Parise, M., Kodio, M., Keita, A. S., Coulibaly, D., et al. (2007). Assessing malaria burden during pregnancy in Mali. Acta Tropica, 102, 106-112. (Pubitemid 46898950)
9. Tukur, I. U., Thacher, T. D., Sagay, A. S., & Madaki, J. K. (2007). A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women. American Journal of Tropical Medicine and Hygiene, 76, 1019-1023. (Pubitemid 351837859)
10. Schultz, L. J., Steketee, R. W., Macheso, A., Kazembe, P., Chitsulo, L., & Wirima, J. J. (1994). The efficacy of antimalarial regimens containing sulphadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. American Journal of Tropical Medicine and Hygiene, 51, 515-522. (Pubitemid 24378544)
11. Sirima, S. B., Sawadogo, R., Moran, A. C., Konate, A., Diarra, A., Yameogo, M., et al. (2003). Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupela District, Burkina Faso. Clinical Infectious Diseases, 36, 1374-1382. (Pubitemid 36702870)
12. Nahlen, B. L., Alakija, T., Ogunbode, O., Adetoro, O., Akintunde, A., Nguyen-Dinh, P., et al. (1989). Lack of pyrimethamine prophylaxis in pregnant Nigerian women. Lancet, 8667, 830-834. (Pubitemid 19245239)
13. AlKadi, H. O. (2007). Antimalarial drug toxicity: a review. Chemotherapy, 53, 385-391. (Pubitemid 350085250)
14. Newman, R. D., Parise, M. E., Slutsker, L., Nahlen, B., & Steketee, R. W. (2003). Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: Implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. Tropical Medicine and International Health, 8, 488-506. (Pubitemid 36724013)
15. Peters, P. J., Thigpen, M. C., Parise, M. E., & Newman, R. D. (2007). Safety and toxicity of sulfadoxine/pyrimethamine: Implications for malaria prevention in pregnancy using intermittent preventive treatment. Drug Safety, 30(6), 481-501. (Pubitemid 46873074)
16. Shulman, C. E., & Dorman, E. K. (2003). Importance and prevention of malaria in pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 30-35. (Pubitemid 36880725)
17. Greenwood, B. (2004). The use of antimalarial drugs to prevent malaria in the population of malaria-endemic areas. American Journal of Tropical Medicine and Hygiene, 70, 1-7. (Pubitemid 39220508)
18. Federal Ministry of Health (FMOH). (2005). National guidelines and strategies for malaria prevention and control during pregnancy. Federal Ministry of Health, Nigeria, 50 pp.
19. Nyunt, M. M., Adam, I., Kayentao, K., van Dijk, J., Thuma, P., Mauff, K., et al. (2009). Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clin Pharmacol Ther. doi:10.1038/clpt.2009.177.
20. Nosten, F., McGready, R., & Mutabingwa, T. (2007). Case management of malaria in pregnancy. The Lancet Infectious Diseases, 7, 118-125. (Pubitemid 46137945)
21. IPCA. (2006). Sulfadoxine-pyrimethamine-Laridox. Accessed January 3, 2007, from www.malaria-ipca.com.
22. Weidekamm, E., Plozza-Nottebrock, H., Forgo, I., & Dubach, U. C. (1982). Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting. Bulletin of the World Health Organization, 60, 115-122. (Pubitemid 12098094)
23. Bzik, D. J., Li, W. B., Horii, T., & Inselburg, J. (1987). Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proceedings of the National Academy of Sciences of the United States of America, 84, 8360-8364. (Pubitemid 18033451)
24. Sibley, C. H., Hyde, J. E., Sims, P. F., Plowe, C. V., Kublin, J. G., Mberu, E. K., et al. (2001). Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: What next? Trends in Parasitology, 17, 582-588. (Pubitemid 34088118)
25. World Health Organization. (2006). WHO guidelines for the treatment of malaria. Geneva: World Health Organization. WHO/HTM/MAL 2006.1108.
26. Marchesini, P., & Crawley, J. (2004). Reducing the burden of malaria in pregnancy. Roll Back Malaria, Mera I-IV.
27. Olliaro, P. L., Delenne, H., Cisse, M., Badiane, M., Olliaro, A., Vaillant, M., et al. (2008). Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal. Malaria Journal, 7, 234.
28. Mbonye, A. K., Bygbjerg, I. C., & Magnussen, P. (2007). A community-based delivery system of intermittent preventive treatment of malaria in pregnancy and its effect on use of essential maternity care at health units in Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene, 101, 1088-1095. (Pubitemid 47440540)
29. ter Kuile, F., van Eijk, A., & Filler, S. (2007). Effect of sulfadoxine- pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy. JAMA, 297, 2603-2616. (Pubitemid 46961032)
30. Falade, C., Yusuf, B. O., Fadero, F. F., Mokuolu, O. A., Hamer, D. H., & Salako, L. A. (2007). Intermittent preventive treatment with sulfadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria. Malaria Journal, 6, 88.
31. Hommerich, L., von Oertzen, C., Bedu-Addo, G., Holmberg, V., Acquah, P. A., Eggelte, T. A., et al. (2007). Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy. Malaria Journal, 6, 144.
32. Challis, K., Osman, N. B., Cotiro, M., Nordahl, G., Dgedge, M., & Bergstrom, S. (2004). Impact of double dose sulfadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique. Tropical Medicine and International Health, 9, 1066-1073. (Pubitemid 39423084)
33. van Eijk, A. M., Ayisi, J. G., ter Kuile, F. O., Otieno, J. A., Misore, A. O., Odondi, J. O., et al. (2004). Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: A hospital-based based study. Tropical Medicine and International Health, 9, 351-360. (Pubitemid 38365734)
34. Parise, E. M., Ayisi, G. J., Nahlen, L. B., Schultz, J. L., Roberts, M. J., Misore, A., et al. (1998). Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. American Journal of Tropical Medicine and Hygiene, 59, 813-822. (Pubitemid 28524544)
35. Rogerson, S., Chaluluka, E., Kanjala, M., Mkundika, P., Mhango, C., & Molyneux, M. (2000). Intermittent sulfadoxine-pyrimethamine in pregnancy effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94, 549-553.
36. Ramharter, M., Schuster, K., Bouyou-Akotet, M. K., Adegnika, A. A., Schmits, K., Mombo-Ngoma, G., et al. (2007). Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon. American Journal of Tropical Medicine and Hygiene, 77, 418-422. (Pubitemid 351844312)
37. Hastings, I. M., Watkins, W. M., & White, N. J. (2002). The evolution of drug-resistant malaria: the role of drug elimination half-life. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 357, 505-519. (Pubitemid 34489862)
38. Prudhomme O'Meara, W., Smith, D. L., & McKenzie, F. E. (2006). Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Medicine, 3, e141.
39. World Health Organization. (2005). Recommendations on the use of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment during pregnancy (IPT) in areas of moderate to high resistance to SP in the African Region October 2005 World Health Organization. Regional Office for Africa.
40. Dzinjalamala, F. K., Macheso, A. M., Kublin, J. G., Taylor, T. E., Barnes, K. I., Molyneux, M. E., et al. (2005). Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children. Antimicrobial Agents and Chemotherapy, 49, 3601-3606. (Pubitemid 41233006)
41. Massaga, J. J., Kitua, A. Y., Lemnge, M. M., Akida, J. A., Malle, L. N., Ronn, A. M., et al. (2003). Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: A randomised placebo-controlled trial. Lancet, 361, 1853-1860. (Pubitemid 36645180)
42. Watkins, W. M., & Mosobo, M. (1993). Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: Selective pressure for resistance is a function of long elimination half-life. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87(1), 75-78.
43. Hyde, J. E. (1990). The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. Pharmacology and Therapeutics, 48, 45-59. (Pubitemid 20322217)
44. Wang, P., Read, M., Sims, P. F., & Hyde, J. E. (1997). Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Molecular Microbiology, 23, 979-986. (Pubitemid 27096733)
45. Kublin, J. G., Dzinjalamala, F. K., Kamwendo, D. D., Malkin, E. M., Cortese, J. F., Martino, L. M., et al. (2002). Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil- dapsone treatment of Plasmodium falciparum malaria. Journal of Infectious Diseases, 185, 380-388. (Pubitemid 34107252)
46. Schönfeld, M., Miranda, I. B., Schunk, M., Maduhu, I., Maboko, L., Hoelscher, M., et al. (2007). Molecular surveillance of drugresistance associated mutations of Plasmodium falciparum in south-west Tanzania. Malaria Journal, 6, 2.
47. Happi, C. T., Gbotosho, G. O., Folarin, O. A., Akinboye, D. O., Yusuf, B. O., Ebong, O. O., et al. (2005). Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria. Acta Tropica, 95, 183-193. (Pubitemid 41207281)
48. Tamaru, T., & Picciano, M. F. (2006). Folate and human reproduction. American Journal of Clinical Nutrition, 83, 993-1016. (Pubitemid 44713098)
49. Stolzfus, R. J., & Dreyfuss, M. L. (1997). Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia. International Nutritional Anemia Consultative Group (39 pp). Washington, DC: ILSI Press.
50. Ouma, P., Parise, M. E., Hamel, M. J., ter Kuile, F. O., Otieno, K., Ayisi, J. G., et al. (2006). A randomized controlled trial of folate supplementation when treating malaria in pregnancy with sulfadoxine- pyrimethamine. PLoS Clinical Trials, 1, e28.
51. Krungkrai, J., Webster, H. K., & Yuthavong, Y. (1989). De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum. Molecular and Biochemical Parasitology, 32, 25-37.
52. Wang, P., Wang, Q., Aspinall, T. V., Sims, P. F., & Hyde, J. E. (2004). Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum. Molecular Microbiology, 51, 1425-1438. (Pubitemid 38338903)
53. Metz, J. (2007). Folic acid metabolism and malaria. Food and Nutrition Bulletin, 28, S540-S549. (Pubitemid 351149504)
54. Nduati, E., Diriye, A., Ommeh, S., Mwai, L., Kiara, S., Masseno, V., et al. (2008). Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer. Parasitology Research, 102, 1227-1234.
55. Federal Ministry of Health. (2007). Malaria review. Federal Ministry of Health Nigeria.
56. Hill, J., & Kazembe, P. (2006). Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: A review of progress and operational challenges. Tropical Medicine and International Health, 11, 409-418.
57. Briand, V., Cottrell, G., Massougbodji, A., & Cot, M. (2007). Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas. Malaria Journal, 6, 160.
58. Ouma, P. O., Van Eijk, A. M., Hamel, M. J., Sikuku, E., Odhiambo, F., Munguti, K., et al. (2007). The effect of health care worker training on the use of intermittent preventive treatment for malaria in pregnancy in rural western Kenya. Tropical Medicine and International Health, 12(8), 953-961. (Pubitemid 47245828)
59. Akinleye, S. O., Falade, C. O., & Ajayi, I. O. (2009). Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: A cross-sectional study. BMC Pregnancy and Childbirth, 9, 28.
60. Filler, S. J., Kazembe, P., Thigpen, M., Macheso, A., Parise, M. E., Newman, R. D., et al. (2006). Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. Journal of Infectious Diseases, 194, 286-293. (Pubitemid 44116969)
61. Hamer, D. H., Mwanakasale, V., MacLeod, W. B., Chalwe, V., Mukwamataba, D., Champo, D., et al. (2007). Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine- pyrimethamine in HIV-seropositive pregnant Zambian women. Journal of Infectious Diseases, 196, 1585-1594. (Pubitemid 351411955)
62. Gill, C. J., MacLeod, W. B., Mwanakasale, V., Chalwe, V., Mwananyanda, L., Champo, D., et al. (2007). Inferiority of singledose sulfadoxine- pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. Journal of Infectious Diseases, 196, 1577-1584. (Pubitemid 351411954)
63. McGready, R., Davison, B., Stepniewska, K., Cho, T., Shee, H., Brockman, A., et al. (2004). The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. American Journal of Tropical Medicine and Hygiene, 70, 398-407. (Pubitemid 38525553)
64. Gamble, C., Ekwaru, J., & ter Kuile, F. (2006). Insecticide-treated nets for preventing malaria in pregnancy. Cochrane Database Syst Rev, CD003755.
65. White, N. J. (2005). Intermittent presumptive treatment for malaria. PLoS Medicine, 2, 28-33.
66. Sirima, S. B., Cotte, A. H., Konate, A., Moran, A. C., Asamoa, K., Bougouma, E. C., et al. (2006). Malaria prevention during pregnancy: Assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso. American Journal of Tropical Medicine and Hygiene, 75, 205-211. (Pubitemid 46941332)
67. van Eijk, A. M., Ayisi, J. G., ter Kuile, F. O., Slutsker, L., Otieno, J. A., Misore, A. O., et al. (2004). Implementation of intermittent preventive treatment with sulfadoxine-pyrimethamine for control of malaria in pregnancy in Kisumu, western Kenya. Tropical Medicine and International Health, 9, 630-637. (Pubitemid 38657290)
68. Taylor, W., & White, N. (2004). Antimalarial drug toxicity: A review. Drug Safety, 27, 25-61. (Pubitemid 38186936)
69. Andersen, D., Blanc, W., Crozier, D., & Silverman, W. (1956). A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics, 18, 614-625.
70. Forna, F., McConnell, M., & Kitabire, F. N. (2006). Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: Implications for resource-limited settings. AIDS Reviews, 8, 24-36.
71. Brentlinger, P. E., Behrens, C. B., & Micek, M. A. (2006). Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa. The Lancet Infectious Diseases, 6, 100-111. (Pubitemid 43138908)
72. Gimnig, J. E., MacArthur, J. R., M'bang'ombe, M., Kramer, M. H., Chizani, N., Stern, R. S., et al. (2006). Severe cutaneous reactions to sulfadoxine-pyrimethamine and trimethoprim-sulfamethoxazole in Blantyre District, Malawi. American Journal of Tropical Medicine and Hygiene, 74, 738-743. (Pubitemid 46774388)
73. Moore, R., Fortgang, I., Keruly, J., & Chaisson, R. (1996). Adverse events from drug therapy for human immunodeficiency virus disease. American Journal of Medicine, 101, 34-40. (Pubitemid 26285938)
74. Allen, J., Carr, A., Chaisson, R., Freedberg, K., McKay, J., & Polis, M. (1992). Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with HIV. JAMA, 267, 2294-2299.
75. Iyer, J. K., Milhous, W. K., Cortese, J. F., Kublin, J. G., & Plowe, C. V. (2001). Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet, 358, 1066-1067. (Pubitemid 32925132)
76. Duraisingh, M. T., Curtis, J., & Warhurst, D. C. (1998). Plasmodium falciparum: Detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Experimental Parasitology, 89, 1-8. (Pubitemid 28377366)
77. Jelinek, T., Kilian, A. H., Curtis, J., Duraisingh, M. T., Kabagambe, G., von Sonnenburg, F., et al. (1999). Plasmodium falciparum: Selection of serine 108 of dihydrofolate reductase during treatment of uncomplicated malaria with co-trimoxazole in Ugandan children. American Journal of Tropical Medicine and Hygiene, 61, 125-130. (Pubitemid 29345001)
78. Hamel, M. J., Greene, C., Chiller, T., Ouma, P., Polyak, C., Otieno, K., et al. (2008). Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? American Journal of Tropical Medicine and Hygiene, 79, 320-330.
79. Mount, A. M., Mwapasa, V., Elliott, S. R., Beeson, J. G., Tadesse, E., Lema, V. M., et al. (2004). Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet, 363, 1860-1867. (Pubitemid 38748641)
80. Steketee, R., Wirima, J., Hightower, A., Slutsker, L., Heymann, D., & Breman, J. (1996). The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. American Journal of Tropical Medicine and Hygiene, 55, 33-41.
81. Vanhauwere, B., Maradit, H., & Kerr, L. (1998). Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy. American Journal of Tropical Medicine and Hygiene, 58, 17-21. (Pubitemid 28071403)
82. World Health Organization. (1993). Prevention and management of severe anaemia in pregnancy. Geneva: World Health Organization. WHO/FHE/MSM/93.5.
83. National Institutes of Health USA. (2006). Intermittent preventive treatment during pregnancy in Benin: A randomized, open, and equivalent trial comparing sulfadoxine-pyrimethamine with mefloquine. National Institutes of Health USA. http://www.clinicaltrials.gov/ct/show/NCT00274235.
84. Clark, R. L. (2009). Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester. Reproductive Toxicology, 28, 285-296.
85. Kalilani, L., Mofolo, I., Chaponda, M., Rogerson, S. J., Alker, A. P., Kwiek, J. J., et al. (2007). a randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant Women. PLoS One, 2, e1166.
86. Andersen, S. L., Oloo, A. J., Gordon, D. M., Ragama, O. B., Aleman, G. M., Berman, J. D., et al. (1998). Successful double-blinded, randomized, placebo-controlled field trial of azithro-mycin and doxycycline as prophylaxis for malaria in western Kenya. Clinical Infectious Diseases, 26(1), 146-150. (Pubitemid 28068169)
87. Gray, R. H., Wabwire-Mangen, F., Kigozi, G., Sewankambo, N. K., Serwadda, D., Moulton, L. H., et al. (2001). Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. American Journal of Obstetrics and Gynecology, 185(5), 1209-1217. (Pubitemid 33097389)
88. Sarkar, M., Woodland, C. C., Koren, G., & Einarson, A. R. (2006). Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy and Childbirth, 6, 18.